| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | — | +8.7% |
| Cost of Revenue | $954K | — | -3.8% |
| R&D Expense | $156K | — | -16.6% |
| SG&A Expense | $1.1M | — | +25.8% |
| Operating Income | -$190K | — | +11.6% |
| Interest Expense | $35K | — | -14.6% |
| Net Income | -$220K | — | +14.1% |
| EPS (Basic) | -$0.03 | — | +0.0% |
| EPS (Diluted) | -$0.03 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $791K | +9.4% | -7.1% |
| Inventory | $1.8M | +17.1% | +40.9% |
| Current Assets | $3.8M | +11.8% | -0.7% |
| Total Assets | $5.1M | +6.5% | -8.7% |
| Current Liabilities | $5.0M | +10.3% | -1.2% |
| Total Liabilities | $5.0M | +10.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $121K | — | -46.7% |
| Capital Expenditures | $23K | — | +360.0% |
| Investing Cash Flow | -$31K | — | -520.0% |
| Financing Cash Flow | -$150K | — | — |
| Free Cash Flow | $98K | — | -55.9% |
| -6.7% |
| Stockholders' Equity | -$4.2M | -3.8% | -3.2% |